This trial will show if the drug Rotigotine is effective against Restless Legs Syndrome in adolescents, as well as investigating if it is safe to use.
2 Primary · 1 Secondary · Reporting Duration: From Baseline to the end of the Maintenance Period (Day 78)
138 Total Participants · 3 Treatment Groups
Primary Treatment: Rotigotine 2 milligram/24 hours · Has Placebo Group · Phase 3
Age < 18 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: